Inventor
LEE FRANCIS Y
HK19 patents
⚠️ This page may combine multiple inventors who share the name “LEE FRANCIS Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
11 patentsUS6537988B2Mar 25, 2003
Synergistic methods and compositions for treating cancer
BRISTOL MYERS SQUIBB CO139 citations97
US9458156B2Oct 4, 2016
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO25 citations94
US9273014B2Mar 1, 2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO14 citations83
US8999918B2Apr 7, 2015
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO9 citations83
US7622472B2Nov 24, 2009
Combination of Src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
BRISTOL MYERS SQUIBB CO9 citations83
US7537891B2May 26, 2009
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
BRISTOL MYERS SQUIBB CO8 citations80
US7504211B2Mar 17, 2009
Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
BRISTOL MYERS SQUIBB CO3 citations59
US7265260B2Sep 4, 2007
Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
BRISTOL MYERS SQUIBB CO2 citations55
US10112941B2Oct 30, 2018
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations52
US9751879B2Sep 5, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO1 citations51
US9492469B2Nov 15, 2016
Combination therapy for the treatment of proliferative diseases
BRISTOL MYERS SQUIBB CO0 citations51